Florida Senate - 2015                          SENATOR AMENDMENT
       Bill No. CS for CS for SB 7066
       
       
       
       
       
       
                                Ì6390820Î639082                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                                       .                                
                                       .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       Senator Brandes moved the following:
       
    1         Senate Amendment to Amendment (835218) 
    2  
    3         Delete lines 77 - 118
    4  and insert:
    5  Parkinson’s disease, paraplegia, quadriplegia, cachexia, or
    6  terminal illness a physical medical condition that chronically
    7  produces symptoms of seizures or severe and persistent muscle
    8  spasms may recommend order for the patient’s medical use low-THC
    9  cannabis to treat such disease, disorder, or condition; or to
   10  alleviate symptoms of such disease, disorder, or condition; or
   11  to alleviate symptoms caused by a treatment for such disease,
   12  disorder, or condition, if no other satisfactory alternative
   13  treatment options exist for that patient and all of the
   14  following conditions apply:
   15         1.(a) The patient is a permanent resident of this state.
   16         2.(b) The physician determines that the risks of
   17  recommending ordering low-THC cannabis are reasonable in light
   18  of the potential benefit for that patient. If a patient is
   19  younger than 18 years of age, a second physician must concur
   20  with this determination, and such determination must be
   21  documented in the patient’s medical record.
   22         3.(c) The physician registers the patient, the patient’s
   23  legal representative if requested by the patient, and himself or
   24  herself as the recommender orderer of low-THC cannabis for the
   25  named patient on the compassionate use registry maintained by
   26  the department and updates the registry to reflect the contents
   27  of the recommendation order. If the patient is a minor, the
   28  physician must register a legal representative on the
   29  compassionate use registry. The physician shall deactivate the
   30  patient’s registration when treatment is discontinued.
   31         4.(d) The physician maintains a patient treatment plan that
   32  includes the dose, route of administration, planned duration,
   33  and monitoring of the patient’s symptoms and other indicators of
   34  tolerance or reaction to the low-THC cannabis.
   35         5.(e) The physician submits the patient treatment plan, as
   36  well as any other requested medical records, biannually
   37  quarterly to the University of Florida College of Pharmacy for
   38  research on the safety and efficacy of low-THC cannabis on
   39  patients pursuant to subsection (8).
   40         6.(f) The physician obtains the voluntary informed consent
   41  of the patient or the patient’s legal guardian to treatment with
   42  low-THC cannabis after sufficiently explaining the current state
   43  of knowledge in the medical community of the effectiveness of
   44  treatment of the patient’s conditions or symptoms condition with
   45  low-THC cannabis, the medically acceptable alternatives, and the
   46  potential risks and side effects.
   47         7. For a patient who does not have a condition or symptom
   48  other than severe and persistent nausea, seizures, or muscle
   49  spasms, a second physician recommends the patient’s medical use
   50  of low-THC cannabis.
   51         8. For a patient who does not have a condition or symptom
   52  other than severe and persistent pain, a second physician who is
   53  a board-certified pain management physician, as defined in s.
   54  456.44, recommends the patient’s medical use of low-THC
   55  cannabis.